Galaxy Diagnostics, Inc., the science leader in sample enrichment powered testing solutions for elusive flea and tick-borne pathogens, is the exclusive provider of the Lyme Borreliosis Nanotrap® Urine Test.
This first-of-its-kind Lyme Antigen test provides the most sensitive direct detection of Borrelia burgdorferi infection at all stages of the disease. The test provides advantages blood serum testing does not, namely:
-
Identifies positive cases missed by CDC-recommended Two-Tiered Testing (TTT)
-
Reduces concern for false positive results via direct detection of OspA proteins
-
Easy to collect urine samples
The revolutionary test greatly increases the likelihood of Lyme detection via innovative Nanotrap® technology developed by CERES Nanosciences. Nanotrap® particles capture and concentrate low abundance Outer Surface Protein A (OspA) in urine samples, followed by confirmation using a highly sensitive Western blot.